Document Classification

Section Type: RESULTS

Text: Raloxifene use was associated with lower plasma albumin (40. 7 + / - 1. 8 vs. 38. 0 + / - 2. 0 and 38. 5 + / - 2. 3 g/l, for placebo, raloxifene 60 mg/day and raloxifene 120 mg/day, respectively, P = 0. 01), lower plasma total calcium at t = 0 (2. 28 vs. 2. 24 and 2. 21 ; + / - 0. 07 mmol/L ; P = 0. 03), lower plasma total calcium at 50 % of maximal PTH secretion (PTH set-point : 2. 23 + / - 0. 06 vs. 2. 18 + / - 0. 07 and 2. 16 + / - 0. 08 mmol/l, P = 0. 06), and lower plasma non-suppressible PTH (0. 84 + / - 0. 19 vs. 0. 75 + / - 0. 10 and 0. 73 + / - 0. 05 pmol/l, P = 0. 02).